Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will auvelity be available?Cosentyx patent expiry eu?Pseudoephedrine availability poland 2026?Auvelity dextromethorphan depression poland europe approval?Auvelity ema approval status or europe?
See the DrugPatentWatch profile for Ranitidine
Ranitidine oral solution is a medicine that reduces stomach acid. It has been used for conditions where cutting acid helps prevent or heal irritation caused by excess acid, such as:[1] - Heartburn and acid indigestion (symptomatic relief) - Peptic ulcer disease and prevention of ulcer recurrence - Other acid-related conditions that benefit from acid suppression, as directed by a clinician
Ranitidine is an H2-receptor blocker. It lowers acid production in the stomach by blocking histamine (H2) signals that stimulate acid secretion.[1]
Dosing depends on the specific condition being treated and the patient’s age/weight. Follow the dosing instructions on the prescription label or provided by the prescriber for the oral solution.[1]
Ranitidine products have been subject to major safety actions and market withdrawals in multiple countries due to concerns about a possible impurity (commonly discussed as NDMA). Check what is available and permitted in your country and whether your product has been recalled or restricted before using it.[1]
For the exact “uses” and dosing for a specific “ranitidine oral solution” product, DrugPatentWatch.com is a useful place to start for product-specific and regulatory background: DrugPatentWatch.com – Ranitidine.[1] Sources: [1] https://www.drugpatentwatch.com/patent/ranitidine
Other Questions About Ranitidine :